Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of bleomycin, fibrovein and
bleomycin and fibrovein in the treatment of venous malformation.